Equity Mates Investing Podcast cover image

Best of the Best: Riding the waves of disruption - Anshu Sharma | Loftus Peak

Equity Mates Investing Podcast

00:00

GLP‑1 drugs: Lilly versus Novo Nordisk

Anshu explains why Loftus Peak prefers Eli Lilly, citing oral formulations and easier scale-up advantages.

Play episode from 40:42
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app